Concepedia

Domingo G. Pérez

DG

Statistics

Publications

10

Citations

572

H-Index

10

Active since

1985

Affiliations

Mayo Clinic(Current)

Metro-Minnesota Community Oncology Research Consortium

Mayo Clinic in Arizona

Dayton Clinical Oncology Program

Iowa Oncology Research Association

Domingo G. Pérez is an author at Mayo Clinic specializing in medicine, pharmacology, and oncology.

Publications per year

1985–2013

10

Publications

10

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

Ivana N. Micallef, Matthew J. Maurer, Gregory A. Wiseman et al. · Blood · 2011 · 136 citations · Full text

, , +12

Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma

Domingo G. Pérez, Vera J. Suman, Tom R. Fitch et al. · Cancer · 2008 · 126 citations · Full text

, , +17

A randomized phase 2 study of temozolomide and bevacizumab or <i>nab</i> ‐paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma

Lisa A. Kottschade, Vera J. Suman, Domingo G. Pérez et al. · Cancer · 2012 · 84 citations

, , +16

Pilot evaluation of mirtazapine for the treatment of hot flashes.

Domingo G. Pérez, Charles L. Loprinzi, Debra L. Barton et al. · PubMed · 2004 · 64 citations

, , +9

Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma

Roxana Dronca, Jacob B. Allred, Domingo G. Pérez et al. · American Journal of Clinical Oncology · 2013 · 42 citations

, , +17

1–5 of 10